Associations of Thyroid Hormones and Resting Heart Rate in Patients Referred to Coronary Angiography

Abstract

Resting heart rate (RHR) is associated with increased risk of cardiovascular morbidity and mortality. Thyroid hormones exert several effects on the cardiovascular system, but the relation between thyroid function and RHR remains to be further established. We evaluated whether measures of thyroid hormone status are associated with RHR in patients referred to coronary angiography. Thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxin (FT4), and RHR were determined in 2795 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Median (25th to 75th percentile) serum concentrations were 1.25 (0.76–1.92) mU/l for TSH, 4.8 (4.2–5.3) pmol/l for FT3 and 17.1 (15.4-19.0) pmol/l for FT4, and mean (±standard deviation) RHR was 68.8 (±11.7) beats/min. Comparing the highest versus the lowest quartile, RHR (beats/min) was significantly higher in the fourth FT4 quartile [3.48, 95% confidence interval (CI): 2.23–4.73; p <0.001] and in the fourth FT3 quartile (2.30, 95% CI: 1.06–3.55; p <0.001), but there was no significant difference for TSH quartiles. In multiple linear regression analyses adjusting for various potential confounders, FT3 and FT4 were significant predictors of RHR (p <0.001 for both). In subgroups restricted to TSH, FT3, and FT4 values within the reference range, both FT3 and FT4 remained significant predictors of RHR (p <0.001 for all). In conclusion, in patients referred to coronary angiography, FT3 and FT4 but not TSH were positively associated with RHR. The relationship between free thyroid hormones and RHR warrants further investigations regarding its diagnostic and therapeutic implications.

Key words

thyroid hormones - cardiovascular - heart, epidemiology

Publication History

Received: 27 April 2020

Accepted after revision: 27 July 2020

Article published online:
04 September 2020

• References

• 1 Tadic M, Cuspidi C, Grassi G. Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest 2018; 48: e12892
• 2 ó’ Hartaigh B, Bosch JA, Pilz S. et al. Influence of resting heart rate on mortality in patients undergoing coronary angiography (from the Ludwigshafen Risk and Cardiovascular Health [LURIC] study). Am J Cardiol 2012; 110: 515-520
• 3 Aune D, Sen Aó', Hartaigh B. et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 2017; 27: 504-517
• 4 Razvi S, Jabbar A, Pingitore A. et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol 2018; 71: 1781-1796
• 5 Jabbar A, Pingitore A, Pearce SH. et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 2017; 14: 39-55
• 6 Rosário PWS, Calsolari MR. Subclinical hypothyroidism with TSH>7 mIU/l and≤10 mIU/l and coronary artery disease. Horm Metab Res 2020; 52: 85-88
• 7 Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29: 76-131
• 8 Roef GL, Taes YE, Kaufman JM. et al. Thyroid hormone levels within reference range are associated with heart rate, cardiac structure, and function in middle-aged men and women. Thyroid 2013; 23: 947-954
• 9 Zhang Y, Post WS, Cheng A. et al. Thyroid hormones and electrocardiographic parameters: findings from the third national health and nutrition examination survey. PLoS One 2013; 8: e59489
• 10 Dörr M, Ruppert J, Robinson DM. et al. The relation of thyroid function and ventricular repolarization: decreased serum thyrotropin levels are associated with short rate-adjusted QT intervals. J Clin Endocrinol Metab 2006; 91: 4938-4942
• 11 Carvalho RC, Vigário PDS, Chachamovitz DSO. et al. Heart rate response to graded exercise test of elderly subjects in different ranges of TSH levels. Arch. Endocrinol Metab 2018; 62: 591-596
• 12 Wang B, Liu S, Li L. et al. Non-thyroidal illness syndrome in patients with cardiovascular diseases: A systematic review and meta-analysis. Int J Cardiol 2017; 226: 1-10
• 13 Maiden MJ, Torpy DJ. Thyroid hormones in critical illness. Crit Care Clin 2019; 35: 375-388
• 14 Winkelmann BR, März W, Boehm BO. et al. Rationale and design of the LURIC study–a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001; 2 (Suppl. 01) S1-S73
• 15 Merke A, Merke J, Silbernagel G. et al. Free thyroid hormones and mortality in Caucasins undergoing angiography: The Ludwigshafen risk and cardiovascular Health (LURIC) Study. Endocr Pract 2017; 23: 288-298
• 16 Müller P, Dietrich JW, Lin T. et al. Usefulness of serum free thyroxine concentration to predict ventricular arrhythmia risk in euthyroid patients with structural heart disease. Am J Cardiol 2020; 125: 1162-1169
• 17 Dietrich JW, Landgrafe-Mende G, Wiora E. et al. Calculated parameters of thyroid homeostasis: Emerging tools for differential diagnosis and clinical research. Front Endocrinol (Lausanne) 2016; 7: 57
• 18 Hoermann R, Midgley JEM, Larisch R. et al. Recent advances in thyroid hormone regulation: Toward a new paradigm for optimal diagnosis and treatment. Front Endocrinol (Lausanne) 2017; 8: 364
• 19 Flamant F, Cheng SY, Hollenberg AN. et al. Thyroid hormone signaling pathways: Time for a more precise nomenclature. Endocrinology 2017; 158: 2052-2057
• 20 Fitzgerald SP, Bean NG, Falhammar H. et al. Clinical parameters are more likely to be associated with thyroid hormone levels than with thyrotropin levels: A systematic review and meta-analysis. Thyroid 2020; [Epub ahead of print]
• 21 Baumgartner C, da Costa BR, Collet TH. et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation 2017; 136: 2100-2116
• 22 Chaker L, van den Berg ME, Niemeijer MN. et al. Thyroid function and sudden cardiac death: A prospective population-based cohort study. Circulation 2016; 134: 713-722
• 23 Maor E, Kivity S, Kopel E. et al. Differences in heart rate profile during exercise among subjects with subclinical thyroid disease. Thyroid 2013; 23: 1226-32.
• 24 Kaminski G, Makowski K, Michałkiewicz D. et al. The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias. Thyroid 2012; 22: 454-460
• 25 Klein I, Trzepacz PT, Roberts M. et al. Symptom rating scale for assessing hyperthyroidism. Arch Intern Med 1988; 148: 387-390
• 26 Journy NMY, Bernier MO, Doody MM. et al. Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women. Thyroid 2017; 27: 1001-1010
• 27 Lillevang-Johansen M, Abrahamsen B, Jørgensen HL. et al. Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum TSH. J Clin Endocrinol Metab 2017; 102: 2301-2309
• 28 Biondi B, Cooper DS. Subclinical hyperthyroidism. N Engl J Med 2018; 378: 2411-2419
• 29 Abdi H, Gharibzadeh S, Tasdighi E. et al. Associations between thyroid and blood pressure in euthyroid adults: A 9-Year Longitudinal Study. Horm Metab Res 2018; 50: 236-241
• 30 Floriani C, Gencer B, Collet TH. et al. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J 2018; 39: 503-507
• 31 Ruggeri RM, Trimarchi F, Biondi B. Management of endocrine disease: l-Thyroxine replacement therapy in the frail elderly: A challenge in clinical practice. Eur J Endocrinol 2017; 177: R199-R217
• 32 Razvi S. Novel uses of thyroid hormones in cardiovascular conditions. Endocrine 2019; 66: 115-123
• 33 Pingitore A, Mastorci F, Piaggi P. et al. Usefulness of triiodothyronine replacement therapy in patients with ST elevation myocardial infarction and borderline/reduced triiodothyronine levels (from the THIRST Study). Am J Cardiol 2019; 123: 905-912
• 34 Mastorci F, Sabatino L, Vassalle C. et al. Cardioprotection and thyroid hormones in the clinical setting of heart failure. Front Endocrinol (Lausanne) 2020; 10: 927
• 35 Lee JE, Lee DH, Oh TJ. et al. Clinical feasibility of monitoring resting heart rate using a wearable activity tracker in patients with thyrotoxicosis: prospective longitudinal observational study. JMIR Mhealth Uhealth 2018; 6: e159
• 36 Moon JH, Steinhubl SR. Digital medicine in thyroidology: A new era of managing thyroid disease. Endocrinol Metab (Seoul) 2019; 34: 124-131